• Company
  • News
  • Investors
  • Contacts
  • Careers
polypeptide-logopolypeptide-logologo-mobilepolypeptide-logo
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
  • Services
    • GMP Compliance
    • Pre-GMP development
    • Production
    • Quality Assurance
    • Quality control
    • Regulatory Support
  • Commercial Manufacturing
    • Commercial products at PolyPeptide
    • Late stage development
    • Process development and optimization
    • Capacity and Capabilities
  • Custom R&D
    • Custom Research Grade Peptides
    • Radiolabeled peptide
  • Generic peptides
✕
  • Home
  • News
  • Expert views
  • Control strategies for synthetic therapeutic peptide APIs – Part I: Analytical consideration

Control strategies for synthetic therapeutic peptide APIs – Part I: Analytical consideration

2014
Expert views

By Aleksander Swietlow,Harold Rode,Anita Szajek,Michael Verlander,Ivo Eggen,Brian Gregg; BioPharm International, Apr 2014

Read more

Back to news

Related posts

19 December 2025

PolyPeptide showcases leadership in sustainable peptide manufacturing with two landmark publications

Read more
27 November 2025

PolyPeptide’s Approach to Process Intensification: Tackling the increasing Peptide Demand

Read more
13 August 2025

Backbone Protecting Groups for Enhanced Peptide and Protein Synthesis

Read more

Polypeptide Group

INFO

COMPANY
LEADERSHIP
CONTACTS
CAREERS

NEWS

LATEST NEWS
SIGN UP FOR NEWS
EVENTS

SOCIALS

LINKEDIN
YOUTUBE
© Confidentiality 2026 PolyPeptide Group • Cookie Policy • Sitemap • Privacy policy
    • Company
    • News
    • Investors
    • Contacts
    • Careers